Sökning: onr:"swepub:oai:DiVA.org:oru-111379" >
The Determination o...
The Determination of Diabetes Utilities, Costs, and Effects Model : A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation
-
- Szafranski, Kirk (författare)
- EVERSANA, Burlington ON, Canada
-
- De Pouvourville, Gerard (författare)
- ESSEC Business School, Cergy, France
-
- Greenberg, Dan (författare)
- Ben-Gurion University of the Negev, Be'er Sheva, Israel
-
visa fler...
-
- Harris, Stewart (författare)
- University of Western Ontario, London ON, Canada
-
- Jendle, Johan, 1963- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper
-
- Shaw, Jonathan E. (författare)
- Baker Heart and Diabetes Institute, Melbourne VIC, Australia
-
- Coaquira Castro, JeanPierre (författare)
- Formerly of Abbott Diabetes Care, Alameda CA, United States of America
-
- Poon, Yeesha (författare)
- Abbott Diabetes Care, Mississauga, Canada
-
- Levrat-Guillen, Fleur (författare)
- Abbott Diabetes Care, Maidenhead, UK
-
visa färre...
-
(creator_code:org_t)
- Elsevier, 2024
- 2024
- Engelska.
-
Ingår i: Value in Health. - : Elsevier. - 1098-3015 .- 1524-4733. ; 27:4, s. 500-507
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- OBJECTIVE: To assess the accuracy and validity of the DEtermination of Diabetes Utilities, Costs, and Effects (DEDUCE) model, a Microsoft Excel-based tool for evaluating diabetes interventions for type 1 and type 2 diabetes.RESEARCH DESIGN AND METHODS: The DEDUCE model is a patient-level microsimulation, with complications predicted based on the Sheffield and RECODe diabetes models for type 1 and type 2 diabetes, respectively. For this tool to be useful, it must be validated to ensure that its complication predictions are accurate. Internal, external and cross validation was assessed by populating the DEDUCE model with the baseline characteristics and treatment effects reported in clinical trials used in the Fourth, Fifth, and Ninth Mount Hood Diabetes Challenges. Results from the DEDUCE model were evaluated against clinical results and previously validated models via mean absolute percentage error (MAPE) or percentage error.RESULTS: The DEDUCE model performed favorably, predicting key outcomes including cardiovascular disease in type 1 diabetes and all-cause mortality in type 2 diabetes. The model performed well against other models. In the Mount Hood 9 Challenge comparison, error was below the mean reported from comparator models for several outcomes, particularly for hazard ratios.CONCLUSIONS: The DEDUCE model predicts diabetes-related complications from trials and studies well when compared to previously validated models. The model may serve as a useful tool for evaluating the cost-effectiveness of diabetes technologies.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- DEDUCE Model
- Patient-Level Microsimulation
- Sensor-Based Glucose Monitoring Systems
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Szafranski, Kirk
-
De Pouvourville, ...
-
Greenberg, Dan
-
Harris, Stewart
-
Jendle, Johan, 1 ...
-
Shaw, Jonathan E ...
-
visa fler...
-
Coaquira Castro, ...
-
Poon, Yeesha
-
Levrat-Guillen, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
- Artiklar i publikationen
-
Value in Health
- Av lärosätet
-
Örebro universitet